Acute attacks of “thunderstorm asthma” can worsen pollen allergies and exacerbate respiratory conditions. And as climate ...

Breztri becomes the first single-inhaler triple therapy for patients as young as 12 years ...

After breaking through the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has ...

Unexpected asthma triggers can include thirdhand smoke, weather changes, certain chemicals, strong fragrances, wood smoke, ...

The FDA approved Breztri Aerosphere, a single-inhaler triple therapy, as a maintenance treatment for patients aged at least ...

Incorrect inhaler technique reduces drug delivery, worsens asthma control, and increases attacks - proper use, training, and ...

AstraZeneca has scrapped an asthma program after the FLAP inhibitor flopped in a phase 2 trial. | AstraZeneca has scrapped an ...

A machine learning model slightly outperforms a conventional regression model at predicting which children hospitalized for asthma will be readmitted within 180 days.

A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, improved lung function, and reduced attacks. Unlike inhalers, it targets ...

FDA approves Breztri Aerosphere for asthma, introducing the first single-inhaler triple-combination maintenance therapy for ...

Depressive symptoms are common in people with asthma, but increasing evidence suggests they may be driven by biological processes that differ from those seen in major depressive disorder.

A new study published in the Journal of the American Medical Association (JAMA) found 33 per cent of adults recently diagnosed with asthma by their physicians did not have an active form of the ...